1
|
Plentz RR and Malek NP: Clinical
presentation, risk factors and staging systems of
cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 29:245–252.
2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bergquist A and von Seth E: Epidemiology
of cholangiocarcinoma. Best Pract Res Clin Gastroenterol.
29:221–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Rizvi S, Borad MJ, Patel T and Gores GJ:
Cholangiocarcinoma: Molecular pathways and therapeutic
opportunities. Semin Liver Dis. 34:456–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhu AX: Future directions in the treatment
of cholangiocarcinoma. Best Pract Res Clin Gastroenterol.
29:355–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ding X, Zhu F, Yang Y and Li M:
Purification, antitumor activity in vitro of steroidal
glycoalkaloids from black nightshade (Solanum nigrum L.). Food
Chem. 141:1181–1186. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Munari CC, de Oliveira PF, Campos JC,
Martins Sde P, Da Costa JC, Bastos JK and Tavares DC:
Antiproliferative activity of Solanum lycocarpum alkaloidic extract
and their constituents, solamargine and solasonine, in tumor cell
lines. J Nat Med. 68:236–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ding X, Zhu FS, Li M and Gao SG: Induction
of apoptosis in human hepatoma SMMC-7721 cells by solamargine from
Solanum nigrum L. J Ethnopharmacol. 139:599–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sani IK, Marashi SH and Kalalinia F:
Solamargine inhibits migration and invasion of human hepatocellular
carcinoma cells through down-regulation of matrix
metalloproteinases 2 and 9 expression and activity. Toxicol In
Vitro. 29:893–900. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xie X, Zhu H, Yang H, Huang W, Wu Y, Wang
Y, Luo Y, Wang D and Shao G: Solamargine triggers hepatoma cell
death through apoptosis. Oncol Lett. 10:168–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Shiu LY, Chang LC, Liang CH, Huang YS,
Sheu HM and Kuo KW: Solamargine induces apoptosis and sensitizes
breast cancer cells to cisplatin. Food Chem Toxicol. 45:2155–2164.
2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chen Y, Tang Q, Wu J, Zheng F, Yang L and
Hann SS: Inactivation of PI3-K/Akt and reduction of SP1 and p65
expression increase the effect of solamargine on suppressing EP4
expression in human lung cancer cells. J Exp Clin Cancer Res.
34:1542015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liang CH, Shiu LY, Chang LC, Sheu HM, Tsai
EM and Kuo KW: Solamargine enhances HER2 expression and increases
the susceptibility of human lung cancer H661 and H69 cells to
trastuzumab and epirubicin. Chem Res Toxicol. 21:393–399. 2008.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Koff JL, Ramachandiran S and
Bernal-Mizrachi L: A time to kill: Targeting apoptosis in cancer.
Int J Mol Sci. 16:2942–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fulda S: Targeting apoptosis for
anticancer therapy. Semin Cancer Biol. 31:84–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol
Cancer. 14:482015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Fulda S: Targeting extrinsic apoptosis in
cancer: Challenges and opportunities. Semin Cell Dev Biol.
39:20–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lopez J and Tait SW: Mitochondrial
apoptosis: Killing cancer using the enemy within. Br J Cancer.
112:957–962. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Aneknan P, Kukongviriyapan V, Prawan A,
Kongpetch S, Sripa B and Senggunprai L: Luteolin arrests cell
cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in
human cholangiocarcinoma cells. Asian Pac J Cancer Prev.
15:5071–5076. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yang N, Han F, Cui H, Huang J, Wang T,
Zhou Y and Zhou J: Matrine suppresses proliferation and induces
apoptosis in human cholangiocarcinoma cells through suppression of
JAK2/STAT3 signaling. Pharmacol Rep. 67:388–393. 2015. View Article : Google Scholar : PubMed/NCBI
|